- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VRTX
Recent news which mentions VRTX
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
September 16, 2023
From Motley Fool
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
September 15, 2023
Tickers
VRTX
From Benzinga
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2023
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
From Benzinga
Better Bull Market Buy: CRISPR vs. Medtronic Stock
September 14, 2023
From Motley Fool
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
September 10, 2023
From Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
From Motley Fool
1 Top Pharma Growth Stock to Buy Today and Hold Forever
September 08, 2023
Tickers
VRTX
From Motley Fool
2 Top Biotech Stocks to Buy in September
September 08, 2023
From Motley Fool
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
September 08, 2023
Tickers
VRTX
From Motley Fool
September Rally? 3 Stocks to Buy Before Liftoff
September 08, 2023
From InvestorPlace
3 Must-Know Tricks for Investing in Big Pharma Stocks
September 08, 2023
From Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
September 07, 2023
From InvestorPlace
Looking Into Vertex Pharmaceuticals's Recent Short Interest
September 06, 2023
Tickers
VRTX
From Benzinga
3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains
September 05, 2023
From InvestorPlace
With a Prediction for a 70% Gain, Is Wall Street Too Optimistic About This Biotech Stock?
September 05, 2023
From Motley Fool
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
From InvestorPlace
5 Surefire Stocks That Can Build Generational Wealth in 20 Years
September 04, 2023
From Motley Fool
2 Spectacular Growth Stocks You Can Buy in September With No Hesitation
September 03, 2023
From Motley Fool
As Medicare drug-price negotiations inch forward, some states are flexing new powers to cut costs for a broader swath of drugs
September 01, 2023
From MarketWatch
The 3 Most Promising Biotech Stocks to Own Now
August 31, 2023
From InvestorPlace
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
August 28, 2023
From Motley Fool
From Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 Years
August 25, 2023
Tickers
VRTX
From Benzinga
Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy
August 24, 2023
From InvestorPlace
2 No-Brainer Biotech Stocks to Buy Right Now
August 24, 2023
From Motley Fool
3 Clever Tricks to Find Winning Biotech Stocks
August 24, 2023
From Motley Fool
4 Superlative Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
August 19, 2023
From Motley Fool
Peering Into Vertex Pharmaceuticals's Recent Short Interest
August 18, 2023
Tickers
VRTX
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.